Select Page
Why I Stopped Trusting BMI Alone (And What I Use Instead)

Why I Stopped Trusting BMI Alone (And What I Use Instead)

If you’ve ever stepped on the scale, checked your BMI, and been told you’re “normal” while your clothes don’t fit right, your energy is gone, and your labs are telling a different story, I want you to know that you’re not imagining it. BMI was never designed to tell the whole story, and in my clinical practice, I don’t let a single marker make that call.

I want to walk you through a tool I use with my clients that fills in a critical gap BMI leaves wide open: waist-to-height ratio.

 

The Problem With BMI Alone

BMI is a ratio of weight to height. It doesn’t know the difference between muscle and fat, and it has no way of telling you where your fat is actually stored. That second point matters more than most people realize, because fat location changes your risk profile substantially.

Research backs this up in a way that surprised even me. In a large national survey of British adults, 35% of men and 14% of women who fell within a “normal” BMI range were still carrying elevated central fat, the kind of fat distribution linked to real cardiometabolic risk. In other words, BMI alone would have completely missed their risk. That’s not a small blind spot. That’s a significant number of people walking around believing they’re metabolically fine when they aren’t.

 

What Waist-to-Height Ratio Actually Measures

Waist-to-height ratio (WHtR) is exactly what it sounds like: your waist circumference divided by your height, measured in the same units. To calculate it, measure your waist at the belly button, then divide by your height.

The target: keep that number under 0.5. In practical terms, that means your waist circumference should be less than half your height. No complex charts, no calculators required.

Why does this simple ratio outperform BMI in my clinical experience? Because it directly reflects central obesity, the fat stored around your abdomen, which is far more predictive of cardiovascular and metabolic risk than total body weight.

 

The Role of Visceral Fat

Here’s where this gets important. The fat that accumulates around your waist isn’t sitting there passively. Visceral fat surrounds your organs and behaves like an active endocrine tissue. It produces inflammatory compounds, disrupts hormone signaling, and interferes with insulin sensitivity.

This is different from subcutaneous fat, the fat just under the skin that pinches between your fingers. Subcutaneous fat isn’t nearly as metabolically disruptive. Visceral fat is the one driving the inflammation, the fatigue, the brain fog, and the hormone imbalance so many of my clients describe when they come to me feeling unheard by conventional medicine.

 

What a WHtR Above 0.5 Is Associated With

A waist-to-height ratio above 0.5 has been consistently linked to:

  1. Increased cardiovascular risk. Research from the University of Pittsburgh found that people with a BMI under 30, but a WHtR over 0.5, showed higher rates of coronary artery calcification, a marker of future cardiovascular disease, even without other classic risk factors present.
  2. Higher rates of type-2 diabetes and metabolic syndrome. In a study of over 7,000 adults at high cardiovascular risk, WHtR outperformed other anthropometric measurements in predicting type-2 diabetes, hyperglycemia, hypertension, and atherogenic dyslipidemia.
  3. Elevated triglycerides, cholesterol, and blood pressure. Adjusted analyses comparing people above and below the 0.5 threshold found meaningfully higher levels of triglycerides, LDL, HbA1c, fasting glucose, and both systolic and diastolic blood pressure in the higher WHtR group, independent of BMI.
  4. Increased mortality risk at higher levels. A 2025 cohort study found the relationship between WHtR and mortality is J-shaped, with risk climbing more steeply above 0.58. At that level, researchers found meaningfully elevated risk of death from cardiovascular disease, cerebrovascular disease, and diabetes.

 

Why This Matters More During Perimenopause and Postmenopause

I see this constantly in my practice. As estrogen shifts during perimenopause and postmenopause, fat storage patterns change too. Fat that once distributed more evenly, or settled in the hips and thighs, tends to migrate toward the abdomen. This means visceral fat can increase during this life stage even when total body weight barely moves. Your scale might say nothing has changed, while your metabolic risk quietly climbs.

This is exactly why I don’t rely on the scale, or on BMI alone, to assess what’s really going on with a client. A tape measure and a simple ratio tell me more.

 

What I Want You to Do With This

Grab a tape measure. Measure your waist at the belly button. Divide by your height. See where you land.

This single number won’t tell you everything, and I don’t want it to replace a full picture of your health. But alongside the other markers I look at with clients, blood sugar, inflammatory markers, hormone panels, it gives us a clearer, more honest starting point than BMI alone ever could.

If your ratio has you concerned, or if you’ve been told your labs and BMI look “fine” while you feel anything but, I’d love to help you dig into what’s really going on. Root-cause work starts with asking better questions and using better tools, and this is one of the simplest ones I know.

 

References

1     University of Pittsburgh School of Medicine, “Waist-to-Height Ratio Outperforms BMI in Predicting Heart Disease Risk.” medschool.pitt.edu

2     Ashwell, M., et al. “Waist-to-height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: Analysis of data from the British National Diet and Nutrition Survey.” PMC. ncbi.nlm.nih.gov

3     Ashwell, M., et al. “Waist-to-height ratio as an indicator of ‘early health risk.'” PubMed. pubmed.ncbi.nlm.nih.gov

4     Frontiers in Nutrition, “Association of waist-to-height ratio with all-cause and obesity-related mortality in adults: a prospective cohort study.” frontiersin.org

5     PREDIMED study, “Waist-to-Height Ratio and Cardiovascular Risk Factors in Elderly Individuals at High Cardiovascular Risk.” PMC. ncbi.nlm.nih.gov

As of: July 19, 2026

Your Genes and Your Weight: How Nutrigenomics Changes the Conversation on Metabolic Health

Your Genes and Your Weight: How Nutrigenomics Changes the Conversation on Metabolic Health

If you have ever followed exactly the same diet as someone else — a friend, a colleague, a sibling — and had completely different results, you have already experienced nutrigenomics in practice.

One person loses weight easily on a low-carbohydrate approach. Another person follows the same protocol diligently and loses almost nothing. One person takes a standard B-complex and their energy transforms. Another takes the same supplement and feels worse. One person reduces saturated fat and their cholesterol drops dramatically. Another person makes the identical change and their numbers barely shift.

These are not mysteries. They are the predictable results of biochemical individuality — the fact that each of us carries a unique genetic blueprint that profoundly shapes how we process food, metabolize nutrients, regulate inflammation, manage blood sugar, and store fat. Nutrigenomics is the science of understanding that blueprint and using it to inform genuinely personalized nutrition.

I became obsessed with nutrigenomics because of the clarity it offered to my own life experiences. Despite years of being an endurance athlete and following clean nutrition, I continued to struggle with hormonal balance and metabolic resilience during certain periods of my life. Standard nutrition advice never worked for me. Understanding my own genetic terrain and nutrient deficiencies did. And it changed everything about how I work with my clients.

 

What Nutrigenomics Actually Is

Nutrigenomics examines the interaction between your genetic variants — known as single nucleotide polymorphisms, or SNPs — and the nutrients, foods, and dietary patterns you are exposed to. It works in two directions simultaneously.

Nutrigenetics examines how your genes affect your response to nutrition: which nutrients you need more of, which you process poorly, which dietary approaches are likely to be beneficial or counterproductive for your specific physiology. Nutrigenomics also examines how what you eat affects the expression of your genes — because our genetic code is not fixed destiny. Nutrients act directly on gene expression, switching pathways on and off, regulating enzyme production, and influencing which genetic risks materialize and which do not.

The practical application of this is what I do in my practice. I process raw genetic data files from my clients and generate detailed reports that reveal which variants are present, what they mean biochemically, and how nutrition, targeted supplementation, and lifestyle modifications can address the specific pathways those variants affect. I then walk each client through their results and build a protocol that is grounded in their actual genetic physiology — not a generic template.

 

The Key Genes in Metabolic Health and Weight

Several genetic variants have direct and well-studied implications for metabolic health, weight regulation, and the conditions my clients most commonly struggle with.

FTO — the fat mass and obesity gene. FTO variants are among the most widely studied in metabolic health research. Certain variants increase leptin levels while reducing HDL cholesterol, creating an environment of persistent hunger and metabolic disadvantage. Individuals with the higher-risk FTO genotype respond particularly well to personalized dietary interventions and benefit substantially from understanding and working with their specific metabolic predispositions rather than applying generic weight loss approaches.

PPARG — the adipogenesis and insulin sensitivity gene. PPARG regulates how fat cells are formed and how sensitive tissues are to insulin. Variants in this gene influence carbohydrate and fat metabolism and determine in part how a person responds to different dietary macronutrient ratios. Someone with particular PPARG variants may have a significantly different metabolic response to a high-fat diet than someone without them — information that makes generic dietary advice at best ineffective and at worst counterproductive.

FADS1 and FADS2 — the fatty acid desaturase genes. These genes encode the enzymes responsible for converting the shorter-chain omega-3 and omega-6 fatty acids from diet into the longer-chain forms — EPA, DHA, and arachidonic acid — that the body actually uses. Variants in FADS1 and FADS2 significantly affect this conversion efficiency, meaning that some people cannot effectively produce anti-inflammatory DHA and EPA from plant-based omega-3 sources and require preformed EPA and DHA directly. This is one of the reasons I recommend fatty acid testing — because understanding both the genetic conversion capacity and the actual membrane fatty acid ratio gives a complete picture of an individual’s omega-3 status and what is needed to correct it.

MTHFR — the methylation gene. I have dedicated an entire blog to MTHFR, but in the context of metabolic health, its implications deserve mention here. Methylation — the biochemical cycle that MTHFR governs — is involved in insulin regulation, inflammation modulation, gene expression, and the production of the neurotransmitters that influence appetite, mood, and energy. Impaired methylation contributes to elevated homocysteine, which drives vascular inflammation, and to disrupted neurotransmitter balance, which affects the brain’s regulation of hunger and satiety. Addressing MTHFR is not peripheral to metabolic health — it is often central to it.

TNF and IL-6 — the inflammatory genes. Variants in genes encoding inflammatory cytokines like TNF-alpha and interleukin-6 determine in part how robustly the body mounts an inflammatory response and how quickly it resolves it. Those with higher-risk variants may experience more pronounced inflammatory responses to dietary fat, to gut dysbiosis, or to metabolic stress — driving the chronic low-grade inflammation that impairs insulin signaling, disrupts hormone balance, and makes weight loss physiologically difficult. Knowing these variants helps prioritize anti-inflammatory strategies and informs dietary fat choices in ways that generic guidelines cannot.

 

Why Generic Nutrition Advice Will Never Be Enough

Standard dietary guidelines are designed around population averages. They represent what tends to be beneficial for most people most of the time. But metabolic individuality is not marginal — it is the norm. The variation between individuals in how they respond to the same dietary inputs is not small. It is enormous. And for people struggling with weight, insulin resistance, hormonal imbalance, or chronic inflammation that does not respond to standard approaches, that variation is not an academic footnote. It is the reason they have not been getting better.

The conventional nutrition model asks: what should people eat? Nutrigenomics asks: what should this person eat, given their specific genetic, metabolic, and biochemical context? These are fundamentally different questions, and they produce fundamentally different answers.

A woman with FADS2 variants affecting her fatty acid conversion capacity needs more preformed EPA and DHA than someone without those variants — and she needs it in a tested, bioavailable form, not just a generic fish oil capsule. A man with PPARG variants affecting his insulin sensitivity may need a significantly different carbohydrate approach than his partner with a different genetic profile. Someone with compound MTHFR variants needs specific forms of B vitamins — standard forms will not work in their methylation cycle and may actively impair it.

This is not complexity for its own sake. It is precision — the difference between an intervention that works and one that doesn’t.

 

Genes Are Not Destiny

I want to be clear about something important. Understanding your genetic variants is not about receiving a fixed sentence. Genes are not destiny — they give us direction. What nutrigenomics reveals is not what will inevitably happen to you, but what is likely to happen if your nutrition and lifestyle are not calibrated to your specific biology.

The same FTO variant that predisposes someone to excess weight under a standard Western diet may have minimal metabolic consequences when that person understands their specific nutrient needs and eats accordingly. The MTHFR variant that has been driving elevated homocysteine for years can be managed effectively with the right forms of B vitamins. The FADS2 conversion deficit that has been leaving someone chronically omega-3 deficient despite years of fish oil supplementation can be corrected when the actual membrane ratio is tested and the right form and dose of supplementation is applied.

Nutrigenomics does not offer a cure. It offers clarity — a clear, personalized picture of the biological terrain that has been shaping your health, and a roadmap for working with that terrain rather than against it. For people who have spent years doing everything right and still not getting the results they expect, that clarity is not just useful. It is often transformative.

 

What This Looks Like in Practice

In my nutrigenomics consultations, I process raw genetic data and generate a detailed report covering the variants most relevant to my client’s health goals and symptoms. I then conduct a thorough consultation in which I walk them through what their results mean in plain language — what each variant affects, what it means for their specific situation, and what changes to nutrition, supplementation, and lifestyle are indicated.

The report and consultation give clients something most people have never had: a genuine baseline — a biochemically grounded understanding of their individual physiology that they can carry forward for life. Rather than chasing the next diet trend or supplement recommendation, they understand what their body actually needs. Interventions stop being trial and error. They become targeted and evidence based.

This is the future of personalized nutrition. And for many of my clients, it is the first time in years — sometimes decades — that they have finally understood why what they were doing wasn’t working, and what will.


Brigitte Spurgeon is a Board-Certified Functional Genomics Practitioner and Doctor of Orthomolecular Nutrigenomics. She works remotely with clients across the US, Canada, Europe, Asia, Africa, and Australia, offering personalized nutrigenomics consultations, the Metabolic Pathway Strategy, and the Holistic Healing Strategy. To learn more or inquire about working together, visit www.brigittespurgeon.com

This article is for educational purposes and does not constitute medical advice.